Determining Individualized Cancer Therapy in Pancreatic Cancer

Launched by MEDICAL COLLEGE OF WISCONSIN · Jun 14, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how personalized cancer treatments can help adults with pancreatic cancer. Researchers want to understand if tests that analyze the genetic makeup of a tumor can predict how well patients will respond to certain therapies. By reviewing both past and current patient medical records, they will gather information on how effective these personalized treatments are, how long patients live after starting treatment, and any side effects they may experience.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of pancreatic cancer. Participants will be asked to sign a consent form, showing they understand the study. Since this is an observational study, participants will not receive any specific treatment from the trial itself, but their experiences and outcomes will be closely monitored to help improve future treatment options for pancreatic cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years.
• • Pathologically confirmed pancreatic cancer.
• • Ability to understand a written informed consent document and the willingness to sign it
• Exclusion Criteria:
• • Age \<18 years.
• • Primary cancer diagnosis other than pancreatic cancer.